Janus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.30 M
- Revenue Growth 34.80%
- Profit Growth 85.39%
- Ebitda 98.05%
- Net Worth 36.29%
- Total Assets 22.60%
About Janus Life Sciences
Janus Life Sciences Private Limited (JLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 September 2008 and has a history of 16 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.30 M.
Jay Vashisth and Dipti Gupta serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397DL2008PTC182866
- Company No.
182866
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Janus Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipti Gupta  | Director | 04-Sep-2008 | Current |
| Jay Vashisth | Director | 04-Sep-2008 | Current |
Financial Performance of Janus Life Sciences.
Janus Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.8% increase. The company also saw a substantial improvement in profitability, with a 85.39% increase in profit. The company's net worth Soared by an impressive increase of 36.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Janus Life Sciences?
In 2018, Janus Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.30 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.08 Cr
- Punjab National Bank : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 2018 | Others | ₹0.80 M | Open |
| 02 Feb 2013 | Punjab National Bank | ₹0.50 M | Open |
How Many Employees Work at Janus Life Sciences?
Unlock and access historical data on people associated with Janus Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Janus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Janus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.